Summary
Background Over 80% of blindness in Kenya is due to curable or preventable causes, with an estimated 7.5 million Kenyans in need of quality eye care services. Embedding sociodemographic data collection into the national eye screening programme could help identify the groups facing systematic barriers to care. We aimed to determine the sociodemographic characteristics that are associated with access among patients diagnosed with an eye problem and referred for treatment in the national eye screening programme.
Method We used an embedded, pragmatic, cross-sectional study design. A list of sociodemographic questions was developed with input from researchers, community members, policymakers, and programme implementers. After five rounds of iteration, the final sociodemographic question set included the following domains: age, gender, religion, marital status, disability, education, occupation, income, housing, assets, and health insurance. These were integrated into an app that is used to screen, refer, and check-in (register) participants within a major eye screening programme. We gathered data from 4,240 people who screened positive during community screening and were referred to a local outreach treatment clinic in Meru County. We used logistic regression to identify groups for whom services were inaccessible.
Findings Only 46% of those who were referred to local treatment outreach clinics were able to access care. In our fully adjusted model, at the 0.05 level there were no statistically significant differences in the odds of attendance within the domains of disability, health insurance, housing, income, or religion. Strong evidence (p<0.001) was found of an association between access and age, gender, and occupation, with males, younger adults, and those working in sales, services and manual jobs being the least likely to access care.
Conclusions Less than half of those identified with an eye need and referred to free local clinics were able to access care in Meru. Younger people are being left behind, with less than a third of those aged 18-44 receiving care. Future work should explore the barriers and potential solutions to equitably improve access to care for this group.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Institute for Health Research (NIHR) (using the UKs Official Development Assistance (ODA) Funding) and Wellcome [215633/Z/19/Z] under the NIHR-Wellcome Partnership for Global Health Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was granted ethical approval by the Kenya Medical Research Institute (KEMRI) scientific and ethics review unit, and the London School of Hygiene & Tropical Medicine research ethics committee (26541)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Patient-level data will be pseudo-anonymised removing names and any other key identifiers before it is shared. Only the least amount of data will be shared, and where possible it will be fully anonymised and aggregated. All published findings will be at anonymous aggregate subpopulation level. In line with the UK concordat on open research data (2016), anonymised data from this trial will be made available to bona fide research groups (evidenced via CVs and the involvement of a qualified statistician)
